Arkansas Online

A need for heroes

Give blood to aid covid-19 fight

JOHN ARMITAGE John Armitage, MD, is CEO of Arkansas Blood Institute.

Few things these days are as welcome as new tools in the fight against covid-19, and last week, the Food and Drug Administration (FDA) changed the way covid-19 convalescent plasma (CCP) can be used. This specialized type of transfusion is now approved for clinic patients with weakened immune systems to prevent the worsening of their condition.

Hallelujah! We can do more to help the most medically vulnerable avoid hospitalizations, complications and worries.

To capture this benefit, however, a fresh group of blood-donor heroes is urgently needed in January to restock the improved CCP units that will target recent variants, like omicron.

Since repeated pandemic surges have us trapped in an epidemiologic Groundhog Day of recycled warnings, discussions and behaviors, a refresher course on plasma may help.

Plasma is the liquid portion of blood containing immune proteins or antibodies. It can be drawn from recovered patients and then given to boost the anti-viral defenses of recently infected individuals. Convalescent plasma has been around for more than 100 years, and it still has use defeating viruses and other infections.

Encouragingly, a just-published study of more than 1,200 cases showed that outpatients who received CCP were hospitalized at a rate half (46 percent) of that experienced by the control group not receiving the treatment. That can be a huge lightening of the care burden on overwhelmed nurses, doctors and other hospital staff, while also reducing stress on patients and families.

This reworked approach to CCP care is very timely since the FDA announced in December that two of the three monoclonal antibody drugs widely prescribed to combat the early disease are mostly useless against omicron. Of absolutely no surprise given our pandemic circus, there is now a severe shortage of the one effective monoclonal option.

Because the FDA also just adjusted the rules for producing CCP, essentially all of America’s older inventory became unusable. Blood collectors must quickly build back the CCP safety net from scratch.

To do so, we are looking for very specific donors who have proof of symptomatic covid-19 within the last six months and are also more than 10 days out from full recovery. Covid-19 vaccination status does not matter, but there is an age minimum of 18 years. To be clear, it is those very specific fantastic donors who are the key ingredient for producing this beneficial plasma.

Also, to qualify, CCP donors must show high levels of anti-covid-19 antibodies (anti CV19) in their blood. Fortunately, the Arkansas Blood Institute is doing this type of testing for free on all donations in January. Therefore, by simply giving blood this month with the institute, you will be automatically screened in the lab to see if you additionally hit the mark as a potential CCP hero. If you are a candidate, we will contact you to answer a few extra questions and, hopefully, get your “new and improved” unit delivered soon to a patient battling covid-19.

As our community fights yet another round against this deadly virus, I urge you to answer our call. Pass along the immune strength from your recovery to heal a neighbor whose weakened defenses put him or her at risk. Let’s honor all those lost over the last two years by sharing our humanity and our blood to overcome this virus and reduce its devastating toll.

Be a pandemic hero. Give blood now and be a part of someone else’s victory over covid-19.

Voices

en-us

2022-01-20T08:00:00.0000000Z

2022-01-20T08:00:00.0000000Z

https://edition.arkansasonline.com/article/282514366906864

WEHCO Media